243 related articles for article (PubMed ID: 3148132)
1. [Dynamics of the frequency of development of drug resistance in the causative agent of tuberculosis and its effect on the efficacy of treatment of patients with pulmonary tuberculosis].
Abramovskaia AK; Antipova SI
Probl Tuberk; 1988; (10):24-7. PubMed ID: 3148132
[No Abstract] [Full Text] [Related]
2. [Trends in the development of drug resistance in the causative agent of tuberculosis (based on data from an examination of hospital patients)].
Priĭmak AA; Dolzhanskiĭ VM; Sagalovich VIa; El'murzaeva AA
Probl Tuberk; 1985; (8):49-52. PubMed ID: 3932999
[No Abstract] [Full Text] [Related]
3. [Resistance to antitubercular agents in patients with pulmonary tuberculosis treated in the period from 1967 to 1970].
Marsenić B; Panajotović H
Plucne Bolesti Tuberk; 1974; 26 Suppl 2():60-7. PubMed ID: 4216923
[No Abstract] [Full Text] [Related]
4. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
Vojtek J; Holecková R; Rozánek R; Starosta V; Strnad M; Sebests J; Strusa V
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965; 8(5):589-92. PubMed ID: 4955225
[No Abstract] [Full Text] [Related]
5. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
Fomicheva NI; Terentieva AS
Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
[No Abstract] [Full Text] [Related]
6. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
Korotaev GA; Kozulitsyna TI; Tret'iakova EA; Mamed'iarova FA
Probl Tuberk; 1986; (7):32-6. PubMed ID: 3094001
[No Abstract] [Full Text] [Related]
7. [Clinical research: course of pulmonary tuberculosis caused by polyresistant Mycobacterium tuberculosis].
Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
Ann Ist Carlo Forlanini; 1969; 29(4):330-8. PubMed ID: 5004331
[No Abstract] [Full Text] [Related]
8. [Drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis treated in the santorium in Abastumani].
Shilakadze EM; Margadze GKh; Zautashvili MG
Probl Tuberk; 1975; (3):79. PubMed ID: 124432
[No Abstract] [Full Text] [Related]
9. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
Khomenko AG; Chukanov VI; Korneev AA
Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
[TBL] [Abstract][Full Text] [Related]
10. [Drug resistance of Mycobacterium tuberculosis. Behavior of the phenomenon during the past 10 years].
Daddi G; Lucchesi M; Maldarizzi B; Mancini P; Termine A
Ann Ist Carlo Forlanini; 1969; 29(4):286-300. PubMed ID: 5004328
[No Abstract] [Full Text] [Related]
11. [Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis].
Daddi G; Lucchesi M; Mancini P; Rossi P; Sbampato M; Storniello G
Ann Ist Carlo Forlanini; 1969; 29(4):339-48. PubMed ID: 5004332
[No Abstract] [Full Text] [Related]
12. [A new antitubercular agent: rifampicin].
Favez G
Schweiz Rundsch Med Prax; 1970 Feb; 59(8):296-7. PubMed ID: 4996719
[No Abstract] [Full Text] [Related]
13. [Drug resistance of Mycobacterium tuberculosis in coniotuberculosis].
Beskrovnyĭ PS; Varenko IuS; Lastkov OA
Vrach Delo; 1981 Aug; (8):72-4. PubMed ID: 6791383
[No Abstract] [Full Text] [Related]
14. [Effect of aggravating factors on the effectiveness of the treatment of newly detected patients with destructive pulmonary tuberculosis].
Zozuliak VI
Vrach Delo; 1988 Jun; (6):54-5. PubMed ID: 3138824
[No Abstract] [Full Text] [Related]
15. [Incidence of primary and secondary resistance of M. tuberculosis in East Germany in 1983 in hospitalized patients].
Kalich R; Käppler W
Z Erkr Atmungsorgane; 1986; 167(3):254-60. PubMed ID: 3105189
[TBL] [Abstract][Full Text] [Related]
16. [Methods of determining the bacteriostatic activity of the blood and the primary drug resistance of mycobacteria in pulmonary tuberculosis].
Bibik NF
Probl Tuberk; 1980 Feb; (2):63-6. PubMed ID: 6769111
[No Abstract] [Full Text] [Related]
17. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
[TBL] [Abstract][Full Text] [Related]
18. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].
Tsukamura M
Kekkaku; 1978 Oct; 53(10):495-8. PubMed ID: 102861
[No Abstract] [Full Text] [Related]
19. [Resistance of Mycobacterium tuberculosis to the major antitubercular drugs in pulmonary tuberculosis in children and youth previously untreated].
Mordyński K; Piotrowski Z; Szymański A
Gruzlica; 1968 Aug; 36(8):715-8. PubMed ID: 4972465
[No Abstract] [Full Text] [Related]
20. Short-course treatment regimens for patients with tuberculosis.
Dutt AK; Stead WW
Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
